Abstract
The aim of this study was to evaluate the use of a novel porous silica carrier, AEROPERL® 300 Pharma (AP), to improve the in vitro release and oral bioavailability of puerarin (PUE) in solid dispersions (SDs). PUE-AP SD formulations with different ratios of drug to silica (RDS) were prepared by the solvent method. The scanning electron microscopy (SEM) results indicated that the dispersion of PUE improved as the concentration of AP was increased. The differential scanning calorimetry (DSC) and X-ray diffraction (XRD) results revealed that PUE mostly existed in an amorphous state in the SDs. The rate of drug dissolution from the SDs was significantly higher than that from the PUE powder (p < 0.05). The in vitro drug release percentage from the PUE-AP SDs increased as the RDS was reduced. The oral bioavailability of PUE from the SDs improved when using AP, as indicated by AUC(0–∞), which was 2.05 and 2.01 times greater than that of the PUE (API) and PVP K30 SDs, respectively (p < 0.05). The drug content, in vitro release profiles, and the amorphous state of PUE in the PUE-AP SDs showed no significant changes after being stored at room temperature for 6 months or under accelerated conditions (40 ± 2°C, 75 ± 5% relative humidity) for 3 months. AP has a high pore volume, large specific surface area, excellent flowability, and hydrophilic properties, making it capable of improving the dissolution and bioavailability of poorly water-soluble drugs.
Similar content being viewed by others
References
Rowe RC, Sheskey PJ, Cook WG, Fenton ME. Handbook of pharmaceutical excipients. 7th ed. London: The Pharmaceutical Press; 2012.
Meer T, Fule R, Khanna D, Amin P. Solubility modulation of bicalutamide using porous silica. J Pharm Invest. 2013;43:279–85.
Riikonen J, Xu WJ, Lehto VP. Mesoporous systems for poorly soluble drugs—recent trends. Int J Pharm. 2018;536:178–86.
Planinšk O, Kovačič B, Vrečer F. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. Int J Pharm. 2011;406:41–8.
Miura H, Kanebako M, Shirai H, Nakao H, Inagi T, Terada K. Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide. Eur J Pharm Biopharm. 2010;76:215–21.
Li TT, Geng TJ, Md A, Banerjee P, Wang B. BoNovel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Colloids Surf B: Biointerfaces. 2019;176(2):185–93.
Maleki A, Kettiger H, Schoubben A, Rosenholm JM, Ambrogi V, Hamidi M. Mesoporous silica materials: from physico-chemical properties to enhanced dissolution of poorly water-soluble drugs. J Control Release. 2017;262:329–47.
Shen SC, Ng WK, Chia LS, Dong YC, Tan RB. Applications of mesoporous materials as excipients for innovative drug delivery and formulation. Curr Pharm Des. 2013;19(35):6270–89.
Wei QH, Keck CM, Müller RH. Oral hesperidin—amorphization and improved dissolution, properties by controlled loading onto porous silica. Int J Pharm. 2017;518(1–2):253–63.
Pawar JN, Desai HR, Moravkar KK, Khanna DK, Amin PD. Exploring the potential of porous silicas as a carrier system for dissolution rate enhancement of artemether. Asian J Pharm Sci. 2016:760–70.
Alam MA, Ali R, Al-Jenoobi FI, Al-Mohizea AM. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates. Expert Opin Drug Deliv. 2012;9(11):1419–40.
Bikiaris DN. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv. 2011;8:1501–19.
Gao Q, Yang B, Ye ZG, Wang J, Bruce IC, Xia Q. Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin. Eur J Pharmacol. 2007;574:179–84.
Zhou YX, Zhang H, Peng C. Puerarin: a review of pharmacological effects. Phytother Res. 2014;28(7):961–75.
Wei SY, Chen Y. Xu XY. Progress on the pharmacological research of puerarin: a review. Chin J Nat Med. 2014;12(6):407–14.
Jiang XL, Jia YT, Zhang LK, Tian R, Teng YZ. Optimization of self-microemulsifying drug delivery system for puerarin by central composite design-response surface methodology. J Third Mil Med Univ. 2012;34(14):1414–7.
Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Enhanced dissolution and bioavailability of grapefruit flavonoid naringenin by solid dispersion utilizing fourth generation carrier. Drug Dev Ind Pharm. 2015;41(5):772–29.
Seo SW, Han HK, Chun MK, Choi HK. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier. Int J Pharm. 2012;424:18–25.
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China (Volume IV). In: General rule; 2015. p. 0861.
Hattori Y, Haruna Y, Otsuka M. Dissolution process analysis using model-free Noyes-Whitney integral equation. Colloids Surf B: Biointerfaces. 2013;102(1):227–31.
Evonik, 2012. AEROSIL and AEROPERL colloidal silicon dioxide for pharmaceuticals technical information.
Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res. 2000;17(4):397–404.
Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci. 2012;101(2):444–63.
Vogt FG, Roberts-Skilton K, Kennedy-Gabb SA. A solid-state NMR study of amorphous ezetimibe dispersions in mesoporous silica. Pharm Res. 2013;30(9):2315–31.
Li X, Peng H, Tian B, Gou J, Yao Q, Tao X, et al. Preparation and characterization of azithromycin – Aerosil 200 solid dispersions with enhanced physical stability. Int J Pharm. 2015;486(1–2):175–84.
Chauhan B, Shimpi S, Paradkar A. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur J Pharm Sci. 2005;26(2):219–30.
Singh A, Van den Mooter G. Spray drying formulation of amorphous solid dispersions. Adv Drug Deliv Rev. 2016;100:27–50.
Pawar JN, Shete RT, Gangurde AB, Moravkar KK, Javeer SD, Jaiswar DR, et al. Development of amorphous dispersions of artemether with hydrophilic polymers via spray drying: physicochemical and in silico studies. Asian J Pharm Sci. 2016;11(3):385–95.
Zhong L, Zhu X, Yu B, Sn W. Influence of alkalizers on dissolution properties of telmisartan in solid dispersions prepared by cogrinding. Drug Dev Ind Pharm. 2014;40(12):1660–9.
He Y, Ho C. Dispersions: solid amorphous utilization and challenges in drug discovery and development. J Pharm Sci. 2015;104(10):3237–58.
Alshahrani SM, Lu W, Park JB, Morott JT, Alsulays BB, Majumdar S, et al. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF. AAPS PharmSciTech. 2015:1–11.
Ma XY, Williams RO. Characterization of solid amorphous dispersions: an update. J Drug Deliv Sci Technol. 2019;50:113–24.
Rumondor AC, Stanford LA, Taylor LS. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res. 2009;26(12):2599–606.
Li W, Buckton G. Using DVS-NIR to assess the water sorption behaviour and stability of a griseofulvin/PVP K30 solid dispersion. Int J Pharm. 2015;495(2):999–1004.
US Pharmacopoeia (USP 41), 2018.
Ye BN, Wang Z, Feng NP. Solidification of patchouli oil with fumed silica AEROPERL® 300 Pharma. Chin J New Drugs. 2015;24(1):80–4.
Funding
This study was financially supported by Evonik Specialty Chemicals (Shanghai) Co., Ltd. and the National Natural Science Foundation of China (81603308).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All the animal experiments were carried out in accordance with the guidelines of the National Act on the Use of Experimental Animals and were approved by the local ethics committee (SCXK:2013-0016).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, Z., Ye, BN., Zhang, YT. et al. Exploring the Potential of Mesoporous Silica as a Carrier for Puerarin: Characterization, Physical Stability, and In Vivo Pharmacokinetics. AAPS PharmSciTech 20, 289 (2019). https://doi.org/10.1208/s12249-019-1502-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-019-1502-0